PROTEA - Sectoral Emerging Markets Healthcare Fund IF USD

Reference Data

ISIN LU1033754018
Valor Number 23712967
Bloomberg Global ID
Fund Name PROTEA - Sectoral Emerging Markets Healthcare Fund IF USD
Fund Provider Sectoral Asset Management Inc 1010 Sherbrooke St. West, Suite 1610
QC H3A 2R7 Montreal
Canada
Phone: +1 514 849 8777
E-Mail: BusinessDevelopment@sectoral.com
Fund Provider Sectoral Asset Management Inc
Representative in Switzerland FundPartner Solutions (Suisse) SA
Genève 75
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** This Sub-Fund aims to achieve capital growth in USD. While respecting the principle of risk diversification, the Sub-Fund’s net assets are primarily invested in equities, equitylike transferable securities, participation certificates etc. issued by small, mid and large cap companies which are based in an emerging market and/or conduct the majority of their business in an emerging market and are mainly active in the healthcare sector and depositary receipts, such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs), referring to such securities.
Peculiarities

Fund Prices

Current Price * 10.22 USD 04.09.2024
Previous Price * 10.22 USD 03.09.2024
52 Week High * 11.44 USD 15.11.2023
52 Week Low * 9.11 USD 18.04.2024
NAV * 10.22 USD 04.09.2024
Issue Price * 10.22 USD 04.09.2024
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 4,208,851
Unit/Share Assets *** 3,431,731
Trading Information SIX

Performance

YTD Performance -6.67% 29.12.2023
04.09.2024
YTD Performance (in CHF) -6.11% 29.12.2023
04.09.2024
1 month +3.86% 05.08.2024
04.09.2024
3 months +5.04% 04.06.2024
04.09.2024
6 months +1.39% 04.03.2024
04.09.2024
1 year -5.98% 04.09.2023
04.09.2024
2 years -10.35% 05.09.2022
04.09.2024
3 years -46.91% 06.09.2021
04.09.2024
5 years +2.61% 04.09.2019
04.09.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI 0.00
ADDI Date 04.09.2024

Top 10 Holdings ***

Celltrion Inc 6.25%
Samsung BioLogics Co Ltd 5.66%
Apollo Hospitals Enterprise Ltd 5.48%
Dr Reddy's Laboratories Ltd ADR 5.00%
Sun Pharmaceuticals Industries Ltd 4.84%
BeiGene Ltd ADR 4.32%
WuXi Biologics (Cayman) Inc 4.29%
Rede d or Sao Luiz SA Ordinary Shares 4.24%
Bangkok Dusit Medical Services PCL Units Non-Voting Depository Receipt 3.90%
Cipla Ltd 3.59%
Last data update 31.12.2023

Cost / Risk

TER 1.70%
TER date 30.06.2023
Performance Fee ***
PTR
Max. Management Fee *** 1.10%
Ongoing Charges *** 1.58%
SRRI ***
SRRI date *** 31.08.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)